Organization
GC Biopharma
5 clinical trials
Clinical trial
An Open-Label, Phase 1 and Extension Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients With MPS Ⅱ Who Have Central Nervous System Involvement and Are Receiving Treatment With Intravenous DrugStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Phase 1 Study to Evaluate the Safety and the Pharmacokinetics of GC2129A in Healthy Adult Volunteers Under Fasting ConditionsStatus: Recruiting, Estimated PCD: 2023-04-19
Clinical trial
Phase 1 Study to Evaluate the Safety and the Pharmacokinetics of GC2129A in Healthy Adult Volunteers Under Fed ConditionsStatus: Recruiting, Estimated PCD: 2023-04-17
Clinical trial
A Phase 3b Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. in Post-liver Transplant PatientsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
An Open-label, Bridging Study to Assess the Safety and Immunogenicity of BARYCELA Inj. (Live Attenuated Varicella Vaccine for Injection) in Healthy Vietnamese Children Aged Between 12 Months to 12 YearsStatus: Not yet recruiting, Estimated PCD: 2023-04-01